ArticleFrontiers in immunology2022

A radiogenomics biomarker based on immunological heterogeneity for non-invasive prognosis of renal clear cell carcinoma.

Jiahao Gao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.